Withaferin A targeting both cancer stem cells and metastatic cancer stem cells in the UP-LN1 carcinoma cell model

Abstract

Aim: As our understanding of cancer stem cell (CSC) biology improves, search for inhibitory agents of CSCs and metastatic CSCs (mCSCs) positive for CXCR4 is warranted. Withaferin A (WA), a withanolide extracted from the medicinal plant Withania somnifera, has been shown to exhibit anti-cancer effects through multiple mechanisms. Whether WA could selectively target CSCs, mCSCs, or non-CSCs of a gastrointestinal (GI) carcinoma tumor remains unclear.

Methods: Side-population (SP) analysis, flow cytometric phenotyping and sorting, non-invasive imaging in conjunction with xenotransplantation, and immunohistology were used in this investigation.

Results: Using the lymph node metastatic GI cancer cell line UP-LN1, consisting of CD44high/CD24low floating (F) and CD44_low/CD24_high adherent (A) cell subsets, this study demonstrated that as compared with parental UP-LN1 cells or A cells, WA preferentially reduced F-cell proliferation, tumor sphere formation, and SP cells in vitro in greater effi ciencies by apoptosis. This action was mechanistically mediated via the down-regulation of CXCR4/CXCL12 and STAT3/interleukin-6 axes, both of which are instrumental in the acquisition of metastatic ability. Attenuation of interferon-γ-induced CXCR4 expression in F cells by knockdown with siRNA or blocking with an anti-CXCR4 antibody, followed by Western blot analysis, showed signifi cantly reduced metastatic potential in vitro. The extent of in vitro anti-invasive effect of WA on the IFN-γ-treated F cells was signifi cantly greater than on the F cells without WA treatment, or F cells treated with control siRNA or with control IgG antibody. The observed in vitro effects of WA on the CSC and mCSC targeting were validated by data obtained with non-invasive imaging in NOD/SCID mouse xenotransplantation.

Conclusion: WA could effi ciently block the formation of both CSCs and mCSCs in the UP-LN1 cell line, suggesting that WA may be considered an effective therapeutic agent for this type of GI malignancies.

Keywords

Cancer stem cells / CXCR4 / gastrointestinal cancer / metastasis / metastatic cancer stem cells / STAT3 / withaferin A

References

[1] Spano D.Tumor microenvironment: a main actor in the metastasis process..Clin Exp Metastasis2012;29:381-95

[2] Thiery JP.Epithelial-mesenchymal transitions in development and pathologies..Curr Opin Cell Biol2003;15:740-6

[3] Reya T,Clarke MF.Stem cells, cancer, and cancer stem cells..Nature2001;414:105-11

[4] Eyler CE.Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis..J Clin Oncol2008;26:2839-45 PMCID:PMC2739000

[5] Dean M,Bates S.Tumour stem cells and drug resistance..Nat Rev Cancer2005;5:275-84

[6] Rich JN.Cancer stem cells in radiation resistance..Cancer Res2007;67:8980-4

[7] Croker AK.Cancer stem cells: implications for the progression and treatment of metastatic disease..J Cell Mol Med2008;12:374-90 PMCID:PMC3822530

[8] Chang CJ,Chou AS,Porwit-McDonalds A,Larsson C.Immunophenotyic and molecular cytogenetic features of the cell line UP-LN1 established from a lymph node metastasis of a poorly-differentiated carcinoma..Anticancer Res2005;25:683-92

[9] Chen HC,Liu YC,Kang CC,Yeh CT,Liao SK.Induction of metastatic cancer stem cells from the NK/LAK-resistant floating, but not adherent, subset of the UP-LN1 carcinoma cell line by IFN-gamma..Lab Invest2011;91:1502-13

[10] Wu MS,Ruppertb JG.Cytokeratin 8-MHC class I interactions: a potential novel immune escape phenotype by a lymph node metastatic carcinoma cell line..Biochem Biophys Res Commun2013;441:618-23

[11] Chaffer CL,Scheel C,Wiggins PA,Brooks M,Su Y,Arendt LM,Bierie B.Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state..Proc Natl Acad Sci U S A2011;108:7950-5 PMCID:PMC3093533

[12] Choi MJ,Min KJ,Kwon TK.Endoplasmic reticulum stress mediates withaferin A-induced apoptosis in human renal carcinoma cells..Toxicol In Vitro2011;25:692-8

[13] Hahm ER,Kelley EE,Shiva S.Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species..PLoS One2011;6:e23354

[14] Tai CJ,Chou JF,Hsu CH,Chiu WH,Lee HM.The investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinoma, assisted by non-invasive molecular imaging..BMC Cancer2010;10:95 PMCID:PMC2850900

[15] Mayola E,Esposti DD,Pervaiz S,Debuire B,Brenner C.Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2..Apoptosis2011;16:1014-27

[16] Munagala R,Munjal C.Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells..Carcinogenesis2011;32:1697-705

[17] Stan SD,Warin R.Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo..Cancer Res2008;68:7661-9 PMCID:PMC2562581

[18] Bargagna-Mohan P,Kim YE,Mor-Vaknin N,Liu J,Markovitz DM,Kim KB.The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin..Chem Biol2007;14:623-34 PMCID:PMC3228641

[19] Kakar SS,Powell KS,Miller DM.Withaferin A alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells..PLoS One2014;9:e10756

[20] Patrawala L,Schneider-Broussard R,Claypool K.Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic..Cancer Res2005;65:6207-19

[21] Yang Y,Qi Y,Wu K,Zhao S.Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin..Oncol Rep2015;34:929-35

[22] Kang NY,Ha HH,Chang YT.Embryonic and induced pluripotent stem cell staining and sorting with the live-cell fluorescence imaging probe CDy1..Nat Protoc2011;6:1044-52

[23] Zhang I,Das B,Baruchel S.Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma..Neoplasia2007;9:36-46 PMCID:PMC1803034

[24] Zhou J,Zhang H,Yang Y,Margolick JB,Petricoin E3rd.Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance..Proc Natl Acad Sci U S A2007;104:16158-63 PMCID:PMC2042178

[25] Li HD,Huang KJ,Jiang T,Feng ZZ.STAT3 knockdown reduces pancreatic cancer cell invasiveness and matrix metalloproteinase-7 expression in nude mice..PLoS One2011;6:e25941

[26] Zao Y,Long X,Wang Y.Vimentin affects mobility and invasiveness of prostate cancer cells..Cancer Biochem Funct2008;26:571-7

[27] Mitra A.Cell surface vimentin (CSV) redefines CTCs to monitor cancer progression in patients..J Cancer Prev Curr Res2014;1:00014

[28] Velasco-Vlaquez MA,Lisanti MP.The role of breast cancer stem cells in metastasis and therapeutic implications..Am J Pathol2011;179:2-11 PMCID:PMC3123864

[29] Grover A,Punetha A,Sundar D.Inhibition of the NEMO/IKKß association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A..BMC Genomics2010;11 Suppl 4:S25

[30] Zhao BC,Mao WZ,Han JG,Xu HM.CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma..World J Gastroenterol2011;17:2389-929 PMCID:PMC3103791

[31] Lee HJ,Kim HY,Yun HJ,Kim S.Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer..Int J Oncol2009;34:473-80

[32] Wang J,Roderiquez G,Alvarez R.Role of tyrosine phosphorylation in ligand-independent sequestration of CXCR4 in human primary monocytes-macrophages..J Biol Chem2001;276:49236-43

[33] Vila-Coro AJ,Martín De Ana A,Martínez AC.The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway..FASEB J1999;13:1699-710

[34] Ahr B,Robert-Hebmann V,Biard-Piechaczyk M.Identification of the cytoplasmic domains of CXCR4 involved in Jak2 and STAT3 phosphorylation..J Biol Chem2005;280:6692-700

[35] Bromberg JF.Potential roles of Stat1 and Stat3 in cellular transformation..Cold Spring Harb Symp Quant Biol1999;64:425-8

[36] Bromberg JE,Devgan G,Pestell Y,Darnell JEJr.Stat3 as an oncogene..Cell1999;89:295-303

[37] Niu G,Huang M,Haura E,Zhang S,Sinibaldi D,Heller R,Karras J,Pardoll D,Yu H.Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis..Oncogene2002;21:2000-8

[38] Zhang XW,Piret JM.Cell cycle distribution of primitive haematopoietic cells stimulated in vitro and in vivo..Cell Prolif2001;34:321-30

[39] Pfeiffer M,Leick M,Schmitt-Graeff A.Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung cancer..Br J Cancer2009;100:1949-56 PMCID:PMC2714241

[40] Maroni P,Matteucci E.HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-kB..Carcinogenesis2007;28:267-79

[41] Struchmann K,Steu S,Staller P,Schraml P.pVHL co-ordinately regulates CXCR4/ CCXCL12 and MMP2/MMP9 expression in human clear cell renal cell acrcinoma..J Pathol2008;214:464-71

[42] Yu H,Pardoll D.Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment..Nat Rev Immunol2007;7:41-51

[43] Vermeulen L,Richel DJ.The developing cancer stem-cell model: clinical challenges and opportunities..Lancet Oncol2012;13:e83-9